doomed
2 일 전
Home / Canada/International
Netherlands adds more cannabis growers to experimental retail program
Doomed
April 10, 2025
The Netherlands is expanding the number of licensed cannabis suppliers that are allowed to sell products to the country’s famous “coffee shops” that offer patrons cannabis.
According to the Associated Press, the European Union country is expanding its government-run initiative to 10 municipalities that can sell cannabis from 10 licensed cultivators.
Among the licensed cultivators participating in the program is Village Farms International, which has offices in Vancouver, British Columbia, and Lake Mary, Florida.
Before the allowances took effect, up to 80 coffee shops in 10 Dutch cities were able to acquire cannabis from only three licensed suppliers enrolled in the country’s “wietexperiment,” a historic trial with a licensed supply chain.
The expansion also carried a mandate that, beginning April 7, all coffee shops enrolled in the program can sell only regulated and tracked cannabis, StratCann reported.
After several delays, the pilot program launched in December 2023 in the cities of Breda and Tilburg, where about 19 participating coffee shops began offering both legally grown cannabis and unregulated products.
While home grows remain illegal in the Netherlands, the program allows cannabis cultivators to operate legally for the first time.
For decades, the country’s cannabis stores – also called coffee shops – operated in a system where sales of the drug were legally tolerated while cultivation remained illegal, meaning stores had to procure illicit marijuana products to sell quasi-legally.
Cannabis products allowed in the experiment include:
Dried flower
Edibles
Hashish
Pre-rolls
Amsterdam, the country’s largest city, was denied participation in the experiment.
doomed
2 일 전
Cannabis is dangerous.
Home / All U.S.
House Republicans repeat hemp-derived THC grievances during FDA hearing
Doomed
April 10, 2025
Republican lawmakers repeated familiar concerns about hemp-derived THC products Wednesday during a congressional hearing focused on the U.S. Food and Drug Administration.
But even as hemp advocates begged federal authorities to regulate the industry created by the 2018 Farm Bill, no immediate change to the status quo is in sight.
The theme of the hearing in the Republican-controlled House Committee on Government and Oversight was “Restoring Trust in FDA: Rooting Out Illicit Products.”
The FDA has yet to create regulations for either CBD or nicotine vaporizers, lawmakers pointed out.
And now hemp can be added to that list.
“The FDA has failed to effectively regulate hemp-derived products which the industry themselves desperately want to be regulated,” said U.S. Rep. Marjorie Taylor Greene, a Republican from Georgia.
The hearing not only gave Democrats an opportunity to bash President Donald Trump’s slashing of FDA jobs but also allowed cannabis skeptics such as U.S. Rep. Pete Sessions, R-Texas, to re-air hemp-industry critiques.
Sessions’ comments hint at Republican attitudes toward hemp that might resurface when negotiations over a Farm Bill renewal resume.
Last year, U.S. Rep Mary Miller, R-Illinois, introduced a Farm Bill amendment that would have effectively banned hemp-derived THC.
That tack was followed at the state level in California last fall.
The 2018 Farm Bill, which led to a proliferation of hemp-derived THC products across the country, “doesn’t mention delta-8 (THC) anywhere,” Sessions said.
“What’s happening as a result of this are hemp products become loaded with THC.”
Sessions spoke in front of a poster with an image of rope next to brightly colored packages of products purported to having intoxicating levels of hemp-derived THC.
That’s meant to reemphasize the contention that some lawmakers who voted for the Farm Bill believed they were legalizing industrial products but instead created a barely regulated market that sometimes targets children.
“Marijuana is THC,” Sessions added.
“We have to understand that it is a dangerous product.”
Earlier at the hearing, Jonathan Miller, general counsel of the U.S. Hemp Roundtable, a major Washington, D.C., lobbying group, repeated well-worn calls for a federal agency to regulate the industry – be it the FDA or someone else.
But critics pointed out that the FDA, tasked with regulating pharmaceutical drugs and food products, might not have the resources or the authority to wield power over cannabis products.
doomed
2 일 전
Knowledge is power…
Home / Cultivation
Cannabis industry supply chain already feeling effects of Trump’s tariffs
Chris Casacchia, Staff Writer
April 10, 2025
(This is the first installment of a two-part series exploring the wide-ranging effects of tariffs on the cannabis supply chain. Part 2 is coming Friday.)
Licensed cannabis operators and ancillary companies are bracing for rising business costs, lost customers and vendor backlash in the wake of President Donald Trump’s erratic blanket tariffs that have rattled the global economy and stoked fears of a recession and accelerated inflation in the United States.
Higher prices are expected to take a toll on wide swaths of the industry’s supply chain, from building and cultivation equipment to product components, packaging and raw materials, according to more than a dozen executives and economic experts queried by Doomed after Trump’s “Liberation Day” edict that torpedoed decades of U.S. foreign trade policy.
The tariffs’ effects are already being felt by cannabis businesses – particularly those caught in retaliatory salvos by international vendors – and are leading others to seek more domestic suppliers if and where they can.
Some retailers and brands are planning to pass on some of these rising costs to customers.
They contend margins are already thin in the highly regulated and taxed marijuana sector that competes against a flourishing illicit market, likely to be emboldened by the tariff hikes.
Trump’s so-called “reciprocal” tariff order, particularly targeting manufacturing hubs in Southeast Asia and the European Union (EU) with higher rates, briefly went into effect Wednesday morning.
These tariffs are paid by U.S. businesses to import goods from other countries.
By Wednesday afternoon, Trump had reversed course and announced a 90-day pause on the escalating tariffs, except for China.
Cannabis operators ‘dangerously exposed’
Under the president’s reciprocal tariff plan, several countries in Southeast Asia and the European Union that supply cannabis and ancillary companies with equipment such as point-of-sale systems and raw materials faced double-digit tariff hikes.
China is now facing a 125% tariff after Beijing failed to lift its 34% retaliatory tariff by Trump’s imposed Tuesday deadline in an escalating trade war with the United States’ largest importer and third-largest exporter.
A sweeping 10% tariff, which remains on all products imported from roughly 90 countries, went into effect April 5, triggering a record, two-day sell-off that zapped $6.6 trillion in value from U.S. stock exchanges, The Wall Street Journal reported.
Trump’s policy reversal Wednesday sparked a major comeback on U.S. trading indexes and fueled historic gains, the Associated Press reported.
The AdvisorShares Pure US Cannabis ETF, which tracks U.S. marijuana companies, was still trading near a 52-week low on Wednesday, with shares closing at $2.14.
“Tariffs are no longer a geopolitical footnote,” said Arnaud Dumas de Rauly, founder of cannabis consultancy MayThe5th and chair of VapeSafer, an industry trade group.
“For our industry, they’re a direct threat to profitability and scalability.”
He added: “The cannabis industry is dangerously exposed to global supply-chain risks – many of which just got a lot more expensive overnight.”
Rising material costs
Trump’s policies are already influencing material construction costs, procurement strategies and project risk, industry observers said.
The cost of key inputs such as aluminum, electrical gear and security equipment – a regulatory requirement for plant-touching operators – have increased 10% to 40%, according to Todd Friedman, director of strategic partnerships for Dag Facilities, a Florida-based commercial construction company that designs and builds cultivation operations for cannabis companies.
Material costs for steel framing and conduit have nearly doubled in some regions while lighting and surveillance equipment, commonly sourced from China and Germany, have seen double-digit increases, Friedman added.
Procurement terms are also adjusting, cannabis business leaders said.
Price quotes, once valid for 30-60 days, have been minimized to a few days.
Upfront deposits or full prepayments also have been initiated to secure pricing, adding more strain to cash flow.
In response, contractors are including larger contingencies into bids and contract clauses for sudden price-hike adjustments.
“Clients may face unexpected requests for early payments or need to revise funding strategies mid-project,” Friedman warned.
“Ultimately, tariffs are reshaping how construction projects are planned and executed.”
China’s tariffs hit vape hardware
Most U.S. vape product manufacturers, such as Pax, are in a particular bind since the vast majority of components, including rechargeable lithium-ion batteries, are sourced from China despite recent shifts to other countries.
After Trump’s latest retaliatory strike, the San Francisco-based company is facing an eye-popping 150% cumulative tariff on pods, batteries and all-in-one devices manufactured in China.
That’s because the Biden administration retained a 25% tariff on vape products made in China implemented in 2018 during Trump’s first term.
The company’s Pax Plus and Pax Mini are produced in Malaysia, which was facing a 24% retaliatory tariff.
Economic uncertainty, an anathema to business forecasting and expansion, appears to be the new normal.
“The cannabis and vape supply chains are uniquely complex, and companies across the board are scrambling to assess what these new costs will look like long-term – and how to best absorb them”.
“Countries that once seemed like the most viable manufacturing alternatives to China may no longer be, and the sourcing of component parts is becoming an even more critical part of the equation.”
Tariffs’ impact on genetics
Home growers and licensed cannabis cultivators sourcing premium genetics oversees can also expect price hikes.
“Tariffs on international imports – particularly from key seed-producing countries like the Netherlands and Spain – are likely to lead to a price increase of approximately 10%-20% for European seeds in the U.S. market,” said Eugene Boukreev, head of marketing at Fast Buds, which bills itself as one of the largest auto-seed banks in the world.
The Czech Republic-based company, which sells seeds directly to buyers in over 50 countries, expects tariffs to have a moderate impact on operations.
“European genetics are occasionally used for pheno-hunting and breeding projects, but the overall cost structure of our core business remains stable,” Boukreev added.
“We’re committed to absorbing as much of the additional cost as possible and maintaining current pricing for our customers for as long as we can.”
Kansas City, Missouri-based cannabis producer and brand Illicit Gardens is taking a similar approach with customers.
“The new tariffs are expected to indirectly impact our costs on everything from lighting equipment to packaging,” David Craig, the company’s chief marketing officer, said via email.
“In an industry already navigating tight margins and heavy regulation, even small increases in supply chain expenses can add up.”
doomed
4 일 전
Home / Legal
Outdated state regulations are stifling the cannabis industry
By Doomed
April 8, 2025
The cannabis landscape has shifted dramatically since the first wave of legalization in 2014.
What once were pioneering policies are now outdated shackles, hindering the industry’s growth and failing to meet the evolving needs of consumers and businesses alike.
State marijuana regulators, clinging to frameworks designed for a nascent industry, inadvertently are fuelling the illicit market and creating an economic crisis within the regulated sector by not knowing what they are doing.
Time for a policy reset
The cannabis sector’s initial focus on public safety was understandable.
Concerns about underage access, impaired driving and potential societal impacts dominated the conversation.
However, this singular focus has created a regulatory environment that neglects the crucial element of commercial viability.
The result is a system where licensed businesses struggle to survive while the illicit market continues to thrive.
One glaring example of this regulatory mismatch is the retail-centric model.
While well-intentioned, the forced reliance on brick-and-mortar retail has proved to be a significant barrier to consumer access and, consequently, market growth.
Many consumers – for various reasons, including convenience, privacy or simple preference – are unwilling or unable to visit marijuana stores or medical cannabis dispensaries.
This artificial constraint on demand severely limits the potential of the legal market.
By limiting access, regulators and policymakers inadvertently are suppressing legal participation in the regulated marijuana market.
This has a cascading effect that limits tax revenue, stifles job creation and ultimately undermines the very objectives of legalization.
The promise of a regulated, tax-generating industry that displaces the illicit market is being squandered by outdated policies.
Illicit market is thriving in current regulatory setup.
The persistence of the illicit market is a direct indictment of the current regulatory approach.
Nationally, in 2024, participation in state-regulated marijuana markets was measured at 29.4%, meaning that 70.6% of all cannabis transactions are still conducted in the illicit market.
By failing to create a competitive and accessible legal market, regulators are perpetuating the very problem they sought to solve.
This not only undermines public-policy objectives but also directly contradicts public safety goals.
The illicit market, themselves users, are creating fire that no government or bureaucrats can match.
The current system has created an economic crisis for licensed businesses.
Overregulation, high taxes and limited market access due to poor quality products have created a perfect storm, forcing many businesses to operate at a loss or even close their doors.
In a national survey conducted by Whitney Economics in 2024, only 27.3% of U.S. cannabis businesses were profitable.
This instability not only harms entrepreneurs and investors but also undermines the long-term viability of the regulated marijuana industry.
It is forcing small businesses to fail – the very same businesses that the original state-reform movements were trying to support.
Benefits of changes before federal marijuana reform
The federal landscape, while still complex, is also evolving.
The increasing acceptance of cannabis at the state level – coupled with growing calls for federal reform – necessitates a more adaptable regulatory framework.
Regulations designed for a time when cannabis was universally illegal simply are not appropriate in a world where a growing number of states have embraced regulating marijuana.
It is time for a paradigm shift.
Cannabis regulators must move beyond the narrow focus on public safety and embrace a more holistic approach that considers the economic realities of the industry.
This requires a fundamental rethinking of existing policies, including:
Expanding access: Exploring alternative sales channels (such as delivery services), allowing businesses to open social consumption spaces or limited retail partnerships could significantly increase consumer access and market participation.
Reducing regulatory burdens: Streamlining licensing processes and decreasing excessive compliance costs would help regulated businesses thrive and compete with the illicit market.
Reevaluating tax structures: Implementing more reasonable tax rates would encourage participation in the licensed market and generate more sustainable revenue in the long run.
Harmonizing state and federal regulations: As federal policy evolves, states must be prepared to adapt their regulations to create a more cohesive and efficient national market.
The current regulatory frameworks of states are relics of the past, ill-equipped to handle the present and certainly not the future of the cannabis industry.
A comprehensive policy reset is essential to unlock the full potential of this burgeoning market, protect consumers and finally achieve the public safety and economic benefits promised by regulation.
Continuing down the current path will only perpetuate the problems, further entrenching the illicit market and stifling the growth of a legitimate and potentially transformative industry.
doomed
1 주 전
High just got higher: Trump tariffs to raise prices for US cannabis users
By Mrinalika Roy
April 4, 2025
April 4 (Reuters) - Contemplating smoking your way out of the tariff gloom? Think again.
Sweeping tariffs imposed by U.S. President Donald Trump on Wednesday are set to increase prices of cannabis products in the country, as many firms rely on Asia for manufacturing. The latest levies will stack up on any duties imposed earlier on countries like China, Canada, Mexico and the EU.
Items such as tins, vape hardware and specialized glass remain difficult to source domestically, and companies remain largely dependent on Asia particularly China, analysts and executives
"Those relying on exports from nations with tariffs, such as China, will need to take a serious look at how they might absorb the extra costs or alter partnerships," said Bryan Gerber, CEO of Hara Supply, the world's largest manufacturer of cones and combustibles.
Shares of cannabis firms such as Tilray Brands (TLRY.O), opens new tab, Canopy Growth (WEED.TO), opens new tab, Organigram (OGI.TO), opens new tab and Terrascend (TSND.TO), opens new tab were trading down between 5% and 10% on Thursday.
Most of these tariff costs will be passed to consumers. The higher costs will likely drive more consumers to the illicit market, further denting margins for legal cannabis firms.
"Most cannabis businesses don't have the margin flexibility to absorb a 10%-15% increase," said Mike Forenza, managing partner at AE Global, which makes packaging products for cannabis firms.
Higher costs have already hit demand.
"Manufacturers are passing these tariff cost down the line and it will ultimately impact our customers. We are starting to see a softening in the market and inbound order rates starting to slow," said Brad Wasserstrom, president of Wasserstrom Co, a supply chain firm working with cannabis companies.
The ongoing North America trade spat could exacerbate problems. Things used to grow cannabis crop including compost and peat are imported from Canada and tariffs will make them costlier.
"We work with a manufacturer who imports their glass from China, the wood is imported from Canada, and it's put together in Mexico all before it's distributed in U.S. How is that getting taxed?" said Wasserstrom.
"That's a challenge for everyone and ultimately it will come down to the consumer level."
Hot Features
프리미엄
브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
BottomBounce
5 일 전
